Three isolations of Chaetomium globosum from erythematous epilation of canine skin

References

• de Hoog GS, Guarro J, Gené J, Figueras MJ. Atlas of Clinical Fungi2nd ed. Utrecht, The Netherlands and Universitat Rovira i Virgili ReusSpain: Centraalbureau voor Schimmelcultures, 2000.
   Google Scholar
• Udagawa S, Muroi T, Kurata H, et al. The production of chaetoglobosins, sterigmatocystin, O-methylsterigmatocystin, and chaetocin by Chaetomium spp. and related fungi. Can J Microbiol 1979; 25: 170–177
   PubMed Web of Science ®Google Scholar
• Ohtsubo K, Saito M, Sekita S, Yoshihira K, Natori S. Acute toxic effects of chaetoglobosin A, a new cytochalasan compound produced by Chaetomium globosum, on mice and rats. Jpn J Exp Med 1978; 48: 105–110
   PubMedGoogle Scholar
• Umeda M, Ohtsubo K, Saito M, Sekita S, Yoshihira K.. Cytotoxicity of new cytochalasans from Chaetomium globosum. Experientia 1975; 31: 435–438
   PubMedGoogle Scholar
• Mishra MM, Singh CP, Kapoor KK, Jain MK. Degradation of lignocellulosic material and humus formation by fungi. Ann Microbiol (Paris) A 1979; 130: 481–486
   PubMed Web of Science ®Google Scholar
• Wang S, Li XM, Teuscher F, Li DL, et al. Chaetopyranin, a benzaldehyde derivative, and other related metabolites from Chaetomium globosum, an endophytic fungus derived from the marine red alga Polysiphonia urceolata. J Nat Prod 2006; 69: 1622–1625
   PubMed Web of Science ®Google Scholar
• Kanokmedhakul S, Kanokmedhakul K, Phonkerd N, et al. Antimycobacterial anthraquinone-chromanone compound and diketopiperazine alkaloid from the fungus Chaetomium globosum KMITL-N0802. Planta Med 2002; 68: 834–836
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Groll A, Hiemenz J, et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10(Suppl. 1)48–66
   PubMed Web of Science ®Google Scholar
• Yu J, Yang S, Zhao Y, Li R. A case of subcutaneous phaeohyphomycosis caused by Chaetomium globosum and the sequences analysis of C. globosum. Med Mycol 2006; 44: 541–545
   PubMed Web of Science ®Google Scholar
• Hattori N, Adachi M, Kaneko T, et al. Case report. Onychomycosis due to Chaetomium globosum successfully treated with itraconazole. Mycoses 2000; 43: 89–92
   PubMed Web of Science ®Google Scholar
• Naidu J. Growing incidence of cutaneous and ungual infections by non-dermatophyte fungi at Jabalpur (M.P.). Indian J Pathol Microbiol 1993; 36: 113–118
   PubMedGoogle Scholar
• Stiller MJ, Rosenthal S, Summerbell RC, Pollack J, Chan A. Onychomycosis of the toenails caused by Chaetomium globosum. J Am Acad Dermatol 1992; 26(5 Pt 1)775–776
   PubMed Web of Science ®Google Scholar
• Naidu J, Singh SM, Pouranik M. Onychomycosis caused by Chaetomium globosum Kunze. Mycopathologia 1991; 113: 31–34
   PubMed Web of Science ®Google Scholar
• Costa AR, Porto E, Lacaz Cda S, et al. Cutaneous and ungual phaeohyphomycosis caused by species of Chaetomium Kunze (1817) ex Fresenius, 1829. J Med Vet Mycol 1988; 26: 261–268
   PubMedGoogle Scholar
• Yeghen T, Fenelon L, Campbell CK, et al. Chaetomium pneumonia in patient with acute myeloid leukaemia. J Clin Pathol 1996; 49: 184–186
   PubMed Web of Science ®Google Scholar
• Abbott SP, Sigler L, McAleer R, et al. Fatal cerebral mycoses caused by the ascomycete Chaetomium strumarium. J Clin Microbiol 1995; 33: 2692–2698
   PubMed Web of Science ®Google Scholar
• Anandi V, John TJ, Walter A, et al. Cerebral phaeohyphomycosis caused by Chaetomium globosum in a renal transplant recipient. J Clin Microbiol 1989; 27: 2226–2229
   PubMed Web of Science ®Google Scholar
• Teixeira AB, Trabasso P, Moretti-Branchini ML, et al. Phaeohyphomycosis caused by Chaetomium globosum in an allogeneic bone marrow transplant recipient. Mycopathologia 2003; 156: 309–312
   PubMed Web of Science ®Google Scholar
• Lesire V, Hazouard E, Dequin PF, et al. Possible role of Chaetomium globosum in infection after autologous bone marrow transplantation. Intensive Care Med 1999; 25: 124–125
   PubMed Web of Science ®Google Scholar
• Cabanes FJ, Abarca ML, Bragulat MR, Castella G. Seasonal study of the fungal biota of the fur of dogs. Mycopathologia 1996; 133: 1–7
   PubMed Web of Science ®Google Scholar
• Kurtzman CP, Robnett CJ. Identification of clinically important ascomycetous yeasts based on nucleotide divergence in the 5′ end of the large-subunit (26S) ribosomal DNA gene. J Clin Microbol 1997; 35: 1216–1223
   PubMed Web of Science ®Google Scholar
• National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; approved standard. M38-A. Wayne, PA: National Committee for Clinical Laboratory Standards, 2002.
   Google Scholar
• von Arx JA, Guarro J, Figueras MJ. The ascomycete genus Chaetomium. Beih Nova Hedwigia 1986; 84: 1–162
   Google Scholar
• Serena C, Ortoneda M, Capilla J, et al. In vitro activities of new antifungal agents against Chaetomium spp. and inoculum standardization. Antimicrob Agents Chemother 2003; 47: 3161–3164
   PubMed Web of Science ®Google Scholar
• Walsh TJ, Groll A, Hiemenz J, et al. Infections due to emerging and uncommon medically important fungal pathogens. Clin Microbiol Infect 2004; 10(Suppl. 1)48–66
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004; 42: 4419–4431
   PubMed Web of Science ®Google Scholar
• Nucci M, Marr KA. Emerging fungal diseases. Clin Infect Dis 2005; 41: 521–526
   PubMed Web of Science ®Google Scholar